BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27685626)

  • 1. miRNA-558 promotes gastric cancer progression through attenuating Smad4-mediated repression of heparanase expression.
    Zheng L; Jiao W; Song H; Qu H; Li D; Mei H; Chen Y; Yang F; Li H; Huang K; Tong Q
    Cell Death Dis; 2016 Sep; 7(9):e2382. PubMed ID: 27685626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smad4 suppresses the tumorigenesis and aggressiveness of neuroblastoma through repressing the expression of heparanase.
    Qu H; Zheng L; Jiao W; Mei H; Li D; Song H; Fang E; Wang X; Li S; Huang K; Tong Q
    Sci Rep; 2016 Sep; 6():32628. PubMed ID: 27595937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA-558 promotes tumorigenesis and aggressiveness of neuroblastoma cells through activating the transcription of heparanase.
    Qu H; Zheng L; Pu J; Mei H; Xiang X; Zhao X; Li D; Li S; Mao L; Huang K; Tong Q
    Hum Mol Genet; 2015 May; 24(9):2539-51. PubMed ID: 25616966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA-337-3p inhibits gastric cancer progression through repressing myeloid zinc finger 1-facilitated expression of matrix metalloproteinase 14.
    Zheng L; Jiao W; Mei H; Song H; Li D; Xiang X; Chen Y; Yang F; Li H; Huang K; Tong Q
    Oncotarget; 2016 Jun; 7(26):40314-40328. PubMed ID: 27259238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of MiR-205 transcriptionally suppresses SMAD4 and PTEN and contributes to human ovarian cancer progression.
    Li J; Hu K; Gong G; Zhu D; Wang Y; Liu H; Wu X
    Sci Rep; 2017 Feb; 7():41330. PubMed ID: 28145479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPSE enhancer RNA promotes cancer progression through driving chromatin looping and regulating hnRNPU/p300/EGR1/HPSE axis.
    Jiao W; Chen Y; Song H; Li D; Mei H; Yang F; Fang E; Wang X; Huang K; Zheng L; Tong Q
    Oncogene; 2018 May; 37(20):2728-2745. PubMed ID: 29511351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased miR-146a in gastric cancer directly targets SMAD4 and is involved in modulating cell proliferation and apoptosis.
    Xiao B; Zhu ED; Li N; Lu DS; Li W; Li BS; Zhao YL; Mao XH; Guo G; Yu PW; Zou QM
    Oncol Rep; 2012 Feb; 27(2):559-66. PubMed ID: 22020746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA-584-3p inhibits gastric cancer progression by repressing Yin Yang 1- facilitated MMP-14 expression.
    Zheng L; Chen Y; Ye L; Jiao W; Song H; Mei H; Li D; Yang F; Li H; Huang K; Tong Q
    Sci Rep; 2017 Aug; 7(1):8967. PubMed ID: 28827574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small RNAs targeting transcription start site induce heparanase silencing through interference with transcription initiation in human cancer cells.
    Jiang G; Zheng L; Pu J; Mei H; Zhao J; Huang K; Zeng F; Tong Q
    PLoS One; 2012; 7(2):e31379. PubMed ID: 22363633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-324-3p promotes gastric cancer development by activating Smad4-mediated Wnt/beta-catenin signaling pathway.
    Sun GL; Li Z; Wang WZ; Chen Z; Zhang L; Li Q; Wei S; Li BW; Xu JH; Chen L; He ZY; Ying K; Zhang X; Xu H; Zhang DC; Xu ZK
    J Gastroenterol; 2018 Jun; 53(6):725-739. PubMed ID: 29103082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressor microRNA-31 inhibits gastric carcinogenesis by targeting Smad4 and SGPP2.
    Ruoming W; Zhen Y; Tengteng Z; Jisheng H
    Cancer Gene Ther; 2015 Dec; 22(12):564-72. PubMed ID: 26494556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-κB signaling in gastric carcinogenesis.
    Huang T; Kang W; Zhang B; Wu F; Dong Y; Tong JH; Yang W; Zhou Y; Zhang L; Cheng AS; Yu J; To KF
    Mol Cancer; 2016 Jan; 15():9. PubMed ID: 26801246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional screening for miRNAs targeting Smad4 identified miR-199a as a negative regulator of TGF-β signalling pathway.
    Zhang Y; Fan KJ; Sun Q; Chen AZ; Shen WL; Zhao ZH; Zheng XF; Yang X
    Nucleic Acids Res; 2012 Oct; 40(18):9286-97. PubMed ID: 22821565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notch1 pathway-mediated microRNA-151-5p promotes gastric cancer progression.
    Hsu KW; Fang WL; Huang KH; Huang TT; Lee HC; Hsieh RH; Chi CW; Yeh TS
    Oncotarget; 2016 Jun; 7(25):38036-38051. PubMed ID: 27191259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.
    Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C
    Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-558 facilitates the expression of hypoxia-inducible factor 2 alpha through binding to 5'-untranslated region in neuroblastoma.
    Qu H; Zheng L; Song H; Jiao W; Li D; Fang E; Wang X; Mei H; Pu J; Huang K; Tong Q
    Oncotarget; 2016 Jun; 7(26):40657-40673. PubMed ID: 27276678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of the HOXA10 Promoter Directs miR-196b-5p-Dependent Cell Proliferation and Invasion of Gastric Cancer Cells.
    Shao L; Chen Z; Peng D; Soutto M; Zhu S; Bates A; Zhang S; El-Rifai W
    Mol Cancer Res; 2018 Apr; 16(4):696-706. PubMed ID: 29453320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of heparanase and microRNA-1258 in human non-small cell lung cancer.
    Liu H; Chen X; Gao W; Jiang G
    Tumour Biol; 2012 Oct; 33(5):1327-34. PubMed ID: 22488243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor‑suppressive miR‑299‑3p inhibits gastric cancer cell invasion by targeting heparanase.
    Zhou X; Hu M; Ge Z
    Mol Med Rep; 2019 Sep; 20(3):2151-2158. PubMed ID: 31257534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression.
    Tang H; Deng M; Tang Y; Xie X; Guo J; Kong Y; Ye F; Su Q; Xie X
    Clin Cancer Res; 2013 Oct; 19(20):5602-12. PubMed ID: 23995857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.